Knowledgent and Talend Unveil New Customer-360 Data Management Solution
Kartridge MDM 360 Helps Healthcare, Life Sciences, Finanancial Services and Other Industries Increase Service Levels by Having a More Complete View of Each Customer
"The combination of Knowledgent's industry expertise with Talend's data integration and MDM capabilities on top of Amazon Web Services' cloud storage and database platforms, is a powerful solution for delivering an end-to-end view of patients and research," said Rolf Heimes, senior director, Global Technology Alliances. "We're excited to partner with Knowledgent on bringing this solution to market that promises to help healthcare and life sciences companies more effectively analyze data for better business and patient outcomes."
According to recent Harvard Business Review article, more than 47 percent of data has serious integrity issues causing business analysts to spend 80 percent of their time on searching for and preparing data. Kartridge MDM 360 includes visualization tools that help interpret data hierarchies and contact relationships. This provides a central point of control for data governance and stewardship functions, which helps improve data quality and compliance. Once data quality, curation and governance functions are consolidated, Kartridge MDMD 360 then combines that data with analytical engines and self-service capabilities to contextualize it in a role-based, business employee way. By combining predefined data models, data quality and self-service data discovery, Kartridge MDM 360 empowers data consumers with the information they need, while delivering a trusted 360-degree view of the enterprise. Utilizing AWS S3, Aurora, and Neptune databases, Kartridge MDM 360 can quickly incorporate multiple data resources and scale to support multi-divisional enterprise needs.
"Healthcare and life sciences organizations need effective ways to transform exploding volumes of diverse real-world data into real-world evidence they can leverage with analytics, cognitive computing and the cloud to deliver unprecedented patient value," said Chris Blotto, CIO, Knowledgent. "Kartridge MDM 360 provides an easy-to-deploy, budget-friendly solution for highly regulated healthcare and life sciences organizations, as well as of other industries with customer-centric data needs."
Using Kartridge MDM 360, healthcare and life sciences users can easily locate, combine, cleanse, qualify, and analyze data from a diverse array of sources including EHR and insurance claims systems, clinical trials, patient monitoring devices, smartphones, and social media. Potential use cases for Kartridge MDM 360 include:
- Clinical trial innovation
- Fraud, waste, and abuse analysis
- Scientific search
- Treatment adherence
- Patient recruitment
- Drug responsiveness
- Adverse event processing automation
- Next best action
- Regulatory intelligence
For more information on Knowledgent's Kartridge MDM 360 visit https://knowledgent.com/kartridgemdm360/ or register here to view the live-streamed keynote presentation by Chris Blotto, CTO for Knowledgent, on Wednesday, May 9 at 9:45 am ET. Additional information on Talend and its complete portfolio of offerings can be found at www.talend.com.
Like this Story? Tweet this: #Talend and Knowledgent unveil KartridgeMDM360 to help organizations optimize the information supply chain #TalendConnect
Siobhan Lyons Talend 2024319411 email@example.com
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Talend via Globenewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York
GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Følg saker fra GlobeNewswire
Registrer deg med din epostadresse under for å få de nyeste sakene fra GlobeNewswire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra GlobeNewswire
Compuware Announces Day One Support for IBM CICS Transaction Server for z/OS V5.514.12.2018 18:02 | Pressemelding
SoftServe Achieves Machine Learning Specialization in Google Cloud Partner Program14.12.2018 13:00 | Pressemelding
Google Cloud recognizes SoftServe’s technical proficiency and proven success AUSTIN, Texas, Dec. 14, 2018 (GLOBE NEWSWIRE) -- SoftServe, a leading digital authority and consulting company, announces it achieved the Machine Learning Partner Specialization in the Google Cloud Premier Partner Program. The Partner Specialization affirms SoftServe’s expertise and success building customer solutions in the machine learning field using Google Cloud Platform (GCP) technology. The Google Cloud Partner Specialization Program is designed to provide Google Cloud customers with qualified partners that demonstrate technical proficiency in the specialized solution and service areas. Specifically, the Machine Learning Specialization demonstrates SoftServe’s expertise in data exploration, preprocessing, model training, model evaluation, model deployment, online prediction, and Google Cloud’s pre-trained machine learning APIs. “We teach machines to learn, read, see and understand business data, and make
Minerals Technologies Announces Price Increases for Specialty Minerals Products in Europe14.12.2018 00:01 | Pressemelding
NEW YORK, Dec. 13, 2018 (GLOBE NEWSWIRE) -- Specialty Minerals Inc. (“SMI”), a subsidiary of Minerals Technologies Inc., announced today that effective February 1, 2019, it will increase prices by up to 10% for all coated ultrafine precipitated calcium carbonate (PCC) from SMI’s Lifford Specialty PCC facility in Birmingham, UK, subject to individual customer contracts and market provisions. The price increases reflect increased market demand for higher performance materials, as well as significant inflation in input, raw material and logistics costs. About Minerals Technologies Inc. New York-based Minerals Technologies Inc. (MTI) is a resource- and technology-based growth company that develops, produces and markets worldwide a broad range of specialty mineral, mineral-based and synthetic mineral products and related systems and services. MTI serves the paper, foundry, steel, construction, environmental, energy, polymer and consumer products industries. The Company reported sales of $1.
Synthesio to Bring Proven Ipsos Data Science to Artificial Intelligence13.12.2018 17:03 | Pressemelding
Synthesio's Next-Generation Social Media Intelligence to Raise Unseen Insights to the Surface, Faster NEW YORK, Dec. 13, 2018 (GLOBE NEWSWIRE) -- Synthesio, an Ipsos company, and also the leading Social Media Intelligence Suite, today announced the plans for its next-generation Artificial Intelligence (AI) engine. The project will combine Synthesio’s AI technology with Ipsos’ data science. The combination will power upcoming Synthesio capabilities to help users find insights faster, remove guesswork, and make informed business decisions across a variety of use cases. “Our goal has always been to provide customers with meaningful data, visualized so that they can make strategic business decisions,” explained Loic Moisand, CEO & Founder of Synthesio. “The less guesswork that a company has to make, and the less time that it takes users to find meaningful insights, the more time for data-backed business decisions. We are really pleased that we can leverage the data science capabilities dev
XBiotech Announces Publication of Post-Hoc Analysis for Phase III Colorectal Cancer Study13.12.2018 14:00 | Pressemelding
Biomarkers Predict Significantly Higher Rates of Treatment Response to Bermekimab in Advanced Cancer Patients AUSTIN, Texas, Dec. 13, 2018 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ: XBIT) announced today the publication of findings on key biomarker analysis of colorectal cancer patients treated with bermekimab in its European Phase III study. The manuscript, entitled, “Interleukin-1 Receptor Antagonist (IL-1ra) Levels Predict Favorable Outcome after Bermekimab, a First-in-Class True Human Interleukin-1α Antibody, in a Phase III Randomized Study of Advanced Colorectal Cancer”, has been published online in the journal OncoImmunology. The findings report that patients with relatively low levels of IL-1ra or IL-6 were more likely to respond to bermekimab therapy and achieve the study’s primary endpoint. The study’s primary endpoint measured a combination of physical symptoms—pain, fatigue, anorexia and muscle wasting—which tend to worsen with advanced cancer, to assess whether these sympto
FROM CUTE TO CONFIDENT: MARY KAY INC. TALKS PINK AT THE MUSEUM AT FIT13.12.2018 14:00 | Pressemelding
Mary Kay Inc. and The Museum at The Fashion Institute of Technology Partner for a Pink-Centric Panel Discussion in Conjunction with Special Exhibition ‘Pink: The History of a Punk, Pretty, Powerful Color’ NEW YORK, N.Y., Dec. 13, 2018 (GLOBE NEWSWIRE) -- From pink makeup compacts to the iconic pink Cadillac, global beauty brand Mary Kay has been synonymous with the color pink for more than five decades. On December 13, 2018, Mary Kay will partner with The Museum at FIT (MFIT) to host a scholarly panel discussion, ‘Powerful Pink: From Cute to Confident,’ at the Katie Murphy Amphitheatre on the New York City FIT campus. Panelists include Luis Casco, Mary Kay Global Beauty Ambassador and celebrity makeup artist; Kate Greene, Vice President of Communications and Creative Direction at Givaudan and Karen Young, FIT adjunct professor and founder of The Young Group. The panel discussion will be moderated by Sheryl Adkins-Green, Chief Marketing Officer for Mary Kay Inc. The scholarly panel disc